Recent Posts on This Topic | See All >
Breast cancer drug Abraxane promising for malignant melanoma treatmentTags: arizona cancer center, cancer, melanoma, university of arizona
An approved breast-cancer drug nab-paclitaxel, trade named Abraxane, has been found promising in clinical trial for the treatment of metastatic malignant melanoma, revealed by researchers.
Researchers at the Arizona Cancer Center has used this drug for last 7 years, and resulted in the opening of a Phase 3 clinical trial.
For more information: Breast cancer drug Abraxane promising for malignant melanoma treatment
Now available: “Action and Impact," a 2014 report on the grant programs and activities of the Flinn Foundation in Arizona biosciences, civic leadership, arts and culture, and the Flinn Scholars program.